Youzhou Sang

Youzhou Sang

Auto-generated profile, based on publicly available information

Youzhou Sang

Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
YSYouzhou Sang
Youzhou Sang
LYLi yanxin
Li yanxin
YZYingwen Zhang
Yingwen Zhang
AAAngel A. Alvarez
Angel A. Alvarez
BYBo Yu
Bo Yu
HFHaizhong Feng
Haizhong Feng
Despite the development of adjuvant therapies, glioblastoma (GBM) patients remain incurable, thus justifying the urgent need of new therapies. CDK5 plays a critical role in GBM and is a potential target for GBM. However, the mechanism by which CDK5 promotes GBM tumorigenicity remains largely unknown. Here, we identify TRIM59 as a substrate of CDK5. EGFR-activated CDK5 directly binds to and phosphorylates TRIM59, a ubiquitin ligase at serine 308, which recruits PIN1 for cis–trans isomerization of TRIM59, leading to TRIM59 binding to importin α5 and nuclear translocation. Nuclear TRIM59 induces ubiquitination and degradation of the tumor suppressive histone variant macroH2A1, leading to enhanced STAT3 signaling activation and tumorigenicity. These findings are confirmed by inhibition of CDK5-activated TRIM59 activity that results in suppression of intracranial tumor growth. Correlative expressions of the components of this pathway are clinically prognostic. Our findings suggest targeting CDK5/TRIM59 signaling axis as a putative strategy for treating GBM.

31 March 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
JKJin Wook Kang
Jin Wook Kang
ZZZhiyan Zhan
Zhiyan Zhan
GJGuangzhen Ji
Guangzhen Ji
YSYouzhou Sang
Youzhou Sang
DZDaohong Zhou
Daohong Zhou
TCTao Cheng
Tao Cheng
Maintenance of genetic stability via proper DNA repair in stem and progenitor cells is essential for the tissue repair and regeneration, while preventing cell transformation after damage. Loss of PUMA dramatically increases the survival of mice after exposure to a lethal dose of ionizing radiation (IR), while without promoting tumorigenesis in the long-term survivors. This finding suggests that PUMA (p53 upregulated modulator of apoptosis) may have a function other than regulates apoptosis. Here, we identify a novel role of PUMA in regulation of DNA repair in embryonic or induced pluripotent stem cells (PSCs) and immortalized hematopoietic progenitor cells (HPCs) after IR. We found that PUMA-deficient PSCs and HPCs exhibited a significant higher double-strand break (DSB) DNA repair activity via Rad51-mediated homologous recombination (HR). This is because PUMA can be associated with early mitotic inhibitor 1 (EMI1) and Rad51 in the cytoplasm to facilitate EMI1-mediated cytoplasmic Rad51 ubiquitination and degradation, thereby inhibiting Rad51 nuclear translocation and HR DNA repair. Our data demonstrate that PUMA acts as a repressor for DSB DNA repair and thus offers a new rationale for therapeutic targeting of PUMA in regenerative cells in the context of DNA damage.

31 March 2023
Verified
Other
Open access
DLDeguan Lv
Deguan Lv
FJFeng Jia
Feng Jia
YHYanli Hou
Yanli Hou
YSYouzhou Sang
Youzhou Sang
AAAngel A. Alvarez
Angel A. Alvarez
HFHaizhong Feng
Haizhong Feng

31 March 2023
Verified
Other
Open access
DLDeguan Lv
Deguan Lv
FJFeng Jia
Feng Jia
YHYanli Hou
Yanli Hou
YSYouzhou Sang
Youzhou Sang
AAAngel A. Alvarez
Angel A. Alvarez
HFHaizhong Feng
Haizhong Feng
Effects of KAT6B and KAT5 on AKT phosphorylation and PIK3CA expression.

31 March 2023
Verified
Other
Open access
DLDeguan Lv
Deguan Lv
FJFeng Jia
Feng Jia
YHYanli Hou
Yanli Hou
YSYouzhou Sang
Youzhou Sang
AAAngel A. Alvarez
Angel A. Alvarez
HFHaizhong Feng
Haizhong Feng
Effects of KAT6B and KAT5 on AKT phosphorylation and PIK3CA expression.

31 March 2023
Verified
Other
Open access
DLDeguan Lv
Deguan Lv
FJFeng Jia
Feng Jia
YHYanli Hou
Yanli Hou
YSYouzhou Sang
Youzhou Sang
AAAngel A. Alvarez
Angel A. Alvarez
HFHaizhong Feng
Haizhong Feng